UB Paderborn / Katalog / Suche / in CDI

Qu’est-ce qu’un biosimilaire ? Jusqu’où va la similarité ?: Étude de cas du G-CSF (filgrastim)

Oncologie (Paris, France), 2011-05, Vol.13 (5), p.183-190

2011

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers

Journal of interferon & cytokine research, 1996-10, Vol.16 (10), p.759-764

1996

Volltextzugriff (PDF)

Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone

Fertility and sterility, 1998-02, Vol.69 (2), p.189-194

1998

Volltextzugriff (PDF)

Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone

The journal of clinical endocrinology and metabolism, 1995-02, Vol.80 (2), p.667-673

1995

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone

Fertility and sterility, 1998-02, Vol.69 (2), p.201-209

1998

Volltextzugriff (PDF)

Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH

Fertility and sterility, 1994-04, Vol.61 (4), p.669-678

1994

Volltextzugriff (PDF)

Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration

Fertility and sterility, 1994-04, Vol.61 (4), p.687-695

1994

Volltextzugriff (PDF)

Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay

Fertility and sterility, 1998-02, Vol.69 (2), p.195-200

1998

Volltextzugriff (PDF)

Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide

American journal of physiology: endocrinology and metabolism, 1996-10, Vol.271 (4), p.E775-E787

1996

Volltextzugriff (PDF)

Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone

Drug metabolism and disposition, 1993-01, Vol.21 (1), p.144

1993

Volltextzugriff (PDF)

Importance of quality in biotechnology: the case of the first biological similarity of erythropoietin

Néphrologie & thérapeutique, 2009-02, Vol.5 Spec No1, p.10-15

2009

Volltextzugriff (PDF)

L’importance de la qualité en Biotechnologie : le cas du 1er biosimilaire de l’EPO

Néphrologie & thérapeutique, 2009-02, Vol.5, p.10-15

2009

Volltextzugriff (PDF)

L’importance de la qualité en Biotechnologie : le cas du 1 er biosimilaire de l’EPO

Néphrologie & thérapeutique, 2009, Vol.5, p.10-15

2009

Volltextzugriff (PDF)

Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice

Drug metabolism and disposition, 1992-07, Vol.20 (4), p.592

1992

Volltextzugriff (PDF)

Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics

Fertility and sterility, 1994-04, Vol.61 (4), p.679-686

1994

Volltextzugriff (PDF)

Comprehensive pharmacokinetics of urinary human follicle stimulating hormone in healthy female volunteers

Pharmaceutical research, 1995-06, Vol.12 (6), p.844-850

1995

Volltextzugriff (PDF)

Qu'est-ce qu'un biosimilaire ? Jusqu'où va la similarité ? Étude de cas du G-CSF (filgrastim) : Les Biosimilaires

Oncologie (Paris, France), 2011, Vol.13 (5), p.183-190

2011

Volltextzugriff (PDF)

Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers

Human reproduction (Oxford), 1993-10, Vol.8 (10), p.1604-1611

1993

Volltextzugriff (PDF)

L'importance de la qualité en Biotechnologie : le cas du 1er biosimilaire de l'EPO: Biosimilaires : Nouvelle génération de biomédicaments

Néphrologie & thérapeutique, 2009, Vol.5, p.10-15

2009

Volltextzugriff (PDF)

Treatment of liver disease with malotilate. A pharmacokinetic and pharmacodynamic phase II study in cirrhosis

European journal of clinical pharmacology, 1986-01, Vol.30 (4), p.407-416

1986

Volltextzugriff (PDF)

Food reduces the rate but not the extent of the absorption of theophylline from an aqueous solution

European journal of clinical pharmacology, 1985-01, Vol.28 (2), p.225-227

1985

Volltextzugriff (PDF)

Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone

The journal of clinical endocrinology and metabolism, 1995-02, Vol.80 (2), p.667-673

1995

Volltextzugriff (PDF)

No effect of food on single dose bioavailability of sustained release theophylline ( Sabidal); a comparison between Sabidal and choline theophyllinate solution

International journal of pharmaceutics, 1985, Vol.25 (1), p.113-117

1985

Volltextzugriff (PDF)

Pharmacokinetic study of controlled-release choline theophyllinate in elderly patients

The British journal of clinical practice, 1990-06, Vol.44 (6), p.223

1990

Volltextzugriff (PDF)

Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration: Recombinant FSH: a collection of previously published articles

Fertility and sterility, 1998, Vol.69 (3), p.32s-39s

1998

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Qu’est-ce qu’un biosimilaire ? Jusqu’où va la similarité ?: Étude de cas du G-CSF (filgrastim)

Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers

Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone

Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone

Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone

Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH

Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration

Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay

Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide

Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone

Importance of quality in biotechnology: the case of the first biological similarity of erythropoietin

L’importance de la qualité en Biotechnologie : le cas du 1er biosimilaire de l’EPO

L’importance de la qualité en Biotechnologie : le cas du 1 er biosimilaire de l’EPO

Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice

Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics

Comprehensive pharmacokinetics of urinary human follicle stimulating hormone in healthy female volunteers

Qu'est-ce qu'un biosimilaire ? Jusqu'où va la similarité ? Étude de cas du G-CSF (filgrastim) : Les Biosimilaires

Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers

L'importance de la qualité en Biotechnologie : le cas du 1er biosimilaire de l'EPO: Biosimilaires : Nouvelle génération de biomédicaments

Treatment of liver disease with malotilate. A pharmacokinetic and pharmacodynamic phase II study in cirrhosis

Food reduces the rate but not the extent of the absorption of theophylline from an aqueous solution

Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone

No effect of food on single dose bioavailability of sustained release theophylline ( Sabidal); a comparison between Sabidal and choline theophyllinate solution

Pharmacokinetic study of controlled-release choline theophyllinate in elderly patients

Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration: Recombinant FSH: a collection of previously published articles

Suchergebnisse filtern